<DOC>
	<DOCNO>NCT01471639</DOCNO>
	<brief_summary>The purpose study determine effectiveness , safety , tolerability intranasal ketorolac ( Sprix ) relieve acute pain adult age 18-64 come ED seek care . Considering ED visit , pain common chief complaint . Giving intranasal ketorolac ( Sprix ) stomach dental surgery show safe effective , study investigate use intranasal ketorolac ( Sprix ) treatment acute pain ED . Ketorolac ( Sprix ) several advantage drug commonly give pain , include opioids . Ketorolac ( Sprix ) non-addicting few side effect opioids . The administration ketorolac ( Sprix ) method , IV , intramuscular shot , oral pill form , show safe effective treat acute pain . This study do find give ketorolac ( Sprix ) single dose nasal spray benefit decrease patient 's pain .</brief_summary>
	<brief_title>An Efficacy Safety Trial Intranasal Ketorolac Emergency Department Patients Treatment Acute Pain</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>1 . Patient see emergency department ( ED ) acute pain acute illness injury ( kidney stone acute musculoskeletal injury ) 2 . Age ≥ 18 year &lt; 65 year 3 . Stable patient stable vital sign , include shock ( systolic BP &gt; 90 ) , respiratory failure , multiple trauma patient 4 . Mentally competent patient able understand consent form 5 . Baseline pain score moderate severe ( e.g . NRS ≥ 4 0 10 NRS ≥ 40 0 100 NRS ) 1 . Unstable patient 2 . Multiple trauma patient 3 . Patients allergy ketorolac component nasal spray preparation 4 . Patients active peptic ulcer disease 5 . Patients history asthma , urticaria , allergictype reaction take aspirin NSAIDS 6 . Patients undergo major surgery 7 . Patients renal disease risk renal failure due volume depletion 8 . Pregnant nursing mother 9 . Patients suspect confirmed cerebrovascular bleeding , patient hemorrhagic diathesis , and/or highrisk bleed 10 . Patient nasal abnormality illness could affect absorption intranasal medication ( : nasal discharge , rhinitis , acute upper respiratory infection , acute epistaxis , nasal polyp , nasal tumor ) 11 . Patient contraindication use Sprix , use Sprix would consistent approved package insert 12 . History chronic pain 13 . History drug abuse 14 . History significant neurologic disorder ( could include disease diabetic neuropathy , Parkinson 's disease , etc ) 15 . History significant psychiatric disorder 16 . History medication may affect neurotransmitter ( certain neurologic psychiatric medication ) 17 . No immediate postop patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>18 year old ,</keyword>
	<keyword>previously healthy</keyword>
	<keyword>men nonpregnant woman</keyword>
	<keyword>emergency department</keyword>
</DOC>